Drinking natural small molecule mineral water and asymptomatic hyperuricemia: a multicenter, randomized, double-blind, control study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065860

Enrollment

Unknown

Registered

2022-11-17

Start date

2022-11-17

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic hyperuricemia

Interventions

Treatment group:Drinking natural small molecule mineral water

Control group:Drinking water

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. Blood uric acid value: 420-540 umol/L.

Exclusion criteria

Exclusion criteria: 1. History of gout; 2. Hyperuricemia complications: hypertension, abnormal lipid metabolism, diabetes, obesity, stroke, coronary heart disease, cardiac insufficiency, uric acid nephrolithiasis, renal function damage (>= CKD2 stage); 3. Within 4 weeks after entering the study, they have used uric acid lowering drugs, thiazide diuretics and other drugs that affect uric acid; 4. Pregnancy status; 5. Patients with malignant tumors; 6. The expected life is less than 6 months; 7. Refuse to sign the informed consent form.

Design outcomes

Primary

Measure	Time frame
uric acid;	—

Secondary

Measure	Time frame
gout;Uric acid nephropathy;Renal acid nephrolithiasis;	—

Countries

China

Contacts

Public ContactWu Xianfeng

Shanghai Sixth People's Hospital

xianfengwu2@163.com+86 13917045125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026